{"id":"sublingual-allergen-extract","safety":{"commonSideEffects":[{"rate":null,"effect":"Oral pruritus"},{"rate":null,"effect":"Throat irritation"},{"rate":null,"effect":"Local edema"},{"rate":null,"effect":"Gastrointestinal symptoms"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This immunotherapy works through sublingual immunological tolerance induction, where allergen is placed under the tongue where specialized immune cells (Langerhans cells and dendritic cells) process the antigen and promote regulatory T cell (Treg) development. Over time, repeated exposure leads to a shift from Th2-mediated allergic responses to Th1/Treg-mediated tolerance, reducing allergic symptoms and medication dependence.","oneSentence":"Sublingual allergen extract desensitizes the immune system by gradually exposing it to increasing doses of allergen under the tongue, promoting immune tolerance.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:09:55.867Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis"},{"name":"Allergic asthma"}]},"trialDetails":[{"nctId":"NCT07348302","phase":"PHASE3","title":"Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df","status":"RECRUITING","sponsor":"Inmunotek S.L.","startDate":"2025-04-02","conditions":"Rhinitis, Rhinoconjunctivitis","enrollment":736},{"nctId":"NCT04502966","phase":"PHASE2","title":"Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-11-09","conditions":"Allergic Rhinoconjunctivitis, Grass Pollen Allergy","enrollment":108},{"nctId":"NCT01199133","phase":"PHASE3","title":"Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children","status":"TERMINATED","sponsor":"Stallergenes Greer","startDate":"2009-10","conditions":"Allergic Rhinitis Due to Dust Mite","enrollment":471},{"nctId":"NCT01527188","phase":"PHASE2","title":"Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2010-12-08","conditions":"Allergic Rhinitis Due to House Dust Mite","enrollment":355},{"nctId":"NCT01919554","phase":"PHASE1","title":"Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2013-07","conditions":"Allergic Rhinitis Due to House Dust Mite","enrollment":37},{"nctId":"NCT05113394","phase":"PHASE2","title":"Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy","status":"WITHDRAWN","sponsor":"Boston Children's Hospital","startDate":"2027-02-01","conditions":"Asthma, Allergy","enrollment":""},{"nctId":"NCT06151938","phase":"","title":"Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis","status":"ENROLLING_BY_INVITATION","sponsor":"ALK-Abelló A/S","startDate":"2023-11-21","conditions":"Allergic Rhinitis Due to House Dust Mite, Allergic Asthma","enrollment":100},{"nctId":"NCT05641272","phase":"PHASE2, PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract","status":"NOT_YET_RECRUITING","sponsor":"Inmunotek S.L.","startDate":"2023-11-01","conditions":"Allergic Rhinitis, Allergic Asthma, Allergic Rhinoconjunctivitis","enrollment":90},{"nctId":"NCT05786638","phase":"NA","title":"Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma","status":"COMPLETED","sponsor":"Mansoura University Hospital","startDate":"2021-10-20","conditions":"Efficacy, Self","enrollment":100},{"nctId":"NCT05400811","phase":"PHASE3","title":"Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis","status":"UNKNOWN","sponsor":"Inmunotek S.L.","startDate":"2022-12","conditions":"House Dust Mite Allergy, Perennial Allergic Rhinitis, Allergic Rhinoconjunctivitis","enrollment":400},{"nctId":"NCT02676765","phase":"PHASE3","title":"Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy","status":"TERMINATED","sponsor":"Virginia Commonwealth University","startDate":"2016-06","conditions":"Immunologic Desensitization","enrollment":58},{"nctId":"NCT02654223","phase":"PHASE2","title":"Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy","status":"COMPLETED","sponsor":"Inmunotek S.L.","startDate":"2015-12-30","conditions":"Rhinitis, Rhinoconjunctivitis","enrollment":180},{"nctId":"NCT03763630","phase":"PHASE2","title":"MAPS & ITEC Cohorts: 6-8 Years Follow-up","status":"COMPLETED","sponsor":"University of Southampton","startDate":"2017-09-15","conditions":"Immunotherapy, Allergy and Immunology, Asthma","enrollment":263},{"nctId":"NCT04851860","phase":"PHASE3","title":"Effect of Sublingual Immunotherapy on Platlet factor4 Level in Children","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2021-04-12","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT03388866","phase":"PHASE4","title":"Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis","status":"COMPLETED","sponsor":"Casa Espirita Terra de Ismael","startDate":"2018-05-02","conditions":"Atopic Dermatitis, Effects of Immunotherapy","enrollment":91},{"nctId":"NCT03990272","phase":"PHASE3","title":"Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua","status":"COMPLETED","sponsor":"Beijing Tongren Hospital","startDate":"2017-03-20","conditions":"Allergic Rhinitis","enrollment":702},{"nctId":"NCT02661854","phase":"PHASE2","title":"Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy","status":"UNKNOWN","sponsor":"Inmunotek S.L.","startDate":"2016-06-21","conditions":"Rhinitis, Rhinoconjunctivitis","enrollment":186},{"nctId":"NCT02005627","phase":"PHASE2","title":"Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2013-09-01","conditions":"Allergic Rhinitis","enrollment":46},{"nctId":"NCT02443805","phase":"PHASE3","title":"Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2015-09-29","conditions":"Rhinitis, Allergic, Perennial, House Dust Mite Allergy","enrollment":1607},{"nctId":"NCT02478398","phase":"PHASE3","title":"Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-07-20","conditions":"Rhinitis, Allergic, Seasonal","enrollment":1025},{"nctId":"NCT00580606","phase":"PHASE1, PHASE2","title":"A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2007-12","conditions":"Food Hypersensitivity, Hypersensitivity, Immediate Hypersensitivity","enrollment":40},{"nctId":"NCT03649139","phase":"PHASE3","title":"Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis","status":"COMPLETED","sponsor":"Beijing Tongren Hospital","startDate":"2017-04-01","conditions":"Seasonal Allergic Rhinitis","enrollment":71},{"nctId":"NCT00622362","phase":"PHASE2","title":"Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract","status":"TERMINATED","sponsor":"Laboratorios Leti, S.L.","startDate":"2008-01","conditions":"Allergic Asthma","enrollment":3},{"nctId":"NCT02394600","phase":"PHASE4","title":"The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation","status":"COMPLETED","sponsor":"Queen's University","startDate":"2015-04","conditions":"Allergic Rhinoconjunctivitis","enrollment":93},{"nctId":"NCT02609581","phase":"","title":"Tolerability of SLIT With LAIS® Mites Allergoid Tablets","status":"COMPLETED","sponsor":"University Hospital of Cologne","startDate":"2015-12-01","conditions":"Allergic Rhinitis","enrollment":192},{"nctId":"NCT02295969","phase":"","title":"Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2014-12","conditions":"Allergy","enrollment":307},{"nctId":"NCT00829985","phase":"PHASE1, PHASE2","title":"Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-01","conditions":"Rhinitis, Allergic, Perennial, Asthma","enrollment":54},{"nctId":"NCT01469182","phase":"PHASE3","title":"A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2011-11","conditions":"Allergy","enrollment":914},{"nctId":"NCT00783198","phase":"PHASE2, PHASE3","title":"Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2009-09","conditions":"Rhinitis; Allergic, With Asthma, Conjunctivitis","enrollment":565},{"nctId":"NCT01385371","phase":"PHASE3","title":"A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2011-06","conditions":"Rhinitis Allergic, Conjunctivitis","enrollment":1501},{"nctId":"NCT02256553","phase":"PHASE4","title":"Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2014-10","conditions":"Rhinitis, Allergic, Seasonal","enrollment":102},{"nctId":"NCT00562159","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":439},{"nctId":"NCT00770315","phase":"PHASE2, PHASE3","title":"Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2009-09","conditions":"Rhinitis, Allergic, Conjunctivitis","enrollment":784},{"nctId":"NCT00550550","phase":"PHASE3","title":"Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2007-11","conditions":"Rhinoconjunctivitis, Rhinitis, Conjunctivitis","enrollment":345},{"nctId":"NCT00409409","phase":"PHASE3","title":"Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2006-12","conditions":"Allergy","enrollment":278},{"nctId":"NCT00418379","phase":"PHASE3","title":"Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2006-12","conditions":"Allergy","enrollment":633},{"nctId":"NCT00803244","phase":"PHASE3","title":"Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2009-01","conditions":"Primary Disease","enrollment":381},{"nctId":"NCT00619827","phase":"PHASE1","title":"Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2007-09","conditions":"Seasonal Allergic Rhinitis","enrollment":89},{"nctId":"NCT00367640","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2004-11","conditions":"Allergy","enrollment":628},{"nctId":"NCT00955825","phase":"PHASE3","title":"Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2008-10","conditions":"Allergic Rhinitis Due to Grass Pollens","enrollment":473},{"nctId":"NCT00674700","phase":"PHASE2, PHASE3","title":"Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2007-10","conditions":"Allergic Rhinitis","enrollment":509},{"nctId":"NCT02245360","phase":"PHASE3","title":"Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis","status":"COMPLETED","sponsor":"Abbott","startDate":"2014-10","conditions":"Seasonal Allergic Rhinitis","enrollment":107},{"nctId":"NCT01930461","phase":"PHASE2","title":"Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2013-09","conditions":"Asthma, House Dust Mite Allergy","enrollment":386},{"nctId":"NCT01012882","phase":"PHASE3","title":"Efficacy and Safety of Sublingual Immunotherapy (SLIT)","status":"UNKNOWN","sponsor":"Roxall Medizin","startDate":"2016-11","conditions":"Allergic Rhinitis","enrollment":120},{"nctId":"NCT01014325","phase":"PHASE3","title":"Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy","status":"UNKNOWN","sponsor":"Roxall Medizin","startDate":"2016-09","conditions":"Allergic Rhinitis","enrollment":130},{"nctId":"NCT00841256","phase":"PHASE3","title":"Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children","status":"COMPLETED","sponsor":"Allergopharma GmbH & Co. KG","startDate":"2008-02","conditions":"Allergic Rhinoconjunctivitis","enrollment":207},{"nctId":"NCT00434421","phase":"PHASE1","title":"Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2007-02","conditions":"Allergy, Asthma","enrollment":28},{"nctId":"NCT01353079","phase":"PHASE3","title":"Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy","status":"COMPLETED","sponsor":"Greer Laboratories","startDate":"2011-04","conditions":"Allergy","enrollment":429},{"nctId":"NCT00599872","phase":"PHASE3","title":"Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies","status":"COMPLETED","sponsor":"Greer Laboratories","startDate":"2008-03","conditions":"Allergic Rhinitis","enrollment":430},{"nctId":"NCT01608243","phase":"PHASE1","title":"Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2012-05","conditions":"Asthma, House Dust Mite Allergy","enrollment":94},{"nctId":"NCT01380327","phase":"PHASE1, PHASE2","title":"Biomarkers of Cockroach Sublingual Immunotherapy 2","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-05","conditions":"Asthma, Perennial Allergic Rhinitis","enrollment":99},{"nctId":"NCT00689299","phase":"PHASE2","title":"Phase 2 Study in Adults Sensitized to Cat","status":"COMPLETED","sponsor":"Antigen Laboratories, Inc.","startDate":"2008-10","conditions":"Allergy","enrollment":167},{"nctId":"NCT00264459","phase":"PHASE3","title":"Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture","status":"COMPLETED","sponsor":"Allergopharma GmbH & Co. KG","startDate":"2003-02","conditions":"Grass Pollen Allergy","enrollment":160},{"nctId":"NCT00670384","phase":"PHASE2","title":"Phase 2 Study in Adults Sensitized to Short Ragweed","status":"WITHDRAWN","sponsor":"Antigen Laboratories, Inc.","startDate":"","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT00818181","phase":"PHASE2","title":"Open Label Safety Study of a Birch Pollen Allergen Extract","status":"COMPLETED","sponsor":"Allergopharma GmbH & Co. KG","startDate":"2008-06","conditions":"Rhinoconjunctivitis","enrollment":73},{"nctId":"NCT01052610","phase":"PHASE4","title":"Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites","status":"UNKNOWN","sponsor":"Medical University of Lodz","startDate":"2010-06","conditions":"Bronchial Asthma, Allergic Rhinitis","enrollment":100},{"nctId":"NCT01785394","phase":"PHASE4","title":"POLlinosis and Exhaled Breath Temperature","status":"UNKNOWN","sponsor":"Prof. Todor Popov","startDate":"2012-02","conditions":"Pollinosis","enrollment":60},{"nctId":"NCT01731249","phase":"PHASE3","title":"Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2010-11","conditions":"Hypersensitivity, Allergic Rhinitis, Allergic Conjunctivitis","enrollment":574},{"nctId":"NCT01605760","phase":"PHASE4","title":"House Dust Mite SLIT in Elderly Patients","status":"COMPLETED","sponsor":"Medical University of Silesia","startDate":"2008-01","conditions":"Allergic Rhinitis","enrollment":111},{"nctId":"NCT01506843","phase":"NA","title":"Sublingual Immunotherapy in Children With Allergic Rhinitis","status":"COMPLETED","sponsor":"Federal University of Uberlandia","startDate":"2008-10","conditions":"Allergic Rhinitis","enrollment":122},{"nctId":"NCT00698594","phase":"PHASE4","title":"Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis","status":"COMPLETED","sponsor":"Medical University of Lodz","startDate":"2008-09","conditions":"Allergic Rhinitis","enrollment":60},{"nctId":"NCT00550875","phase":"PHASE2","title":"Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis","status":"COMPLETED","sponsor":"Laboratorios Leti, S.L.","startDate":"2007-06","conditions":"Allergic Rhinoconjunctivitis","enrollment":90},{"nctId":"NCT00537342","phase":"PHASE3","title":"Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT)","status":"COMPLETED","sponsor":"Laboratorios Leti, S.L.","startDate":"2007-10","conditions":"Allergy, Rhinoconjunctivitis","enrollment":83},{"nctId":"NCT00501527","phase":"PHASE2","title":"Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense","status":"COMPLETED","sponsor":"Laboratorios Leti, S.L.","startDate":"2007-09","conditions":"Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic, Asthma","enrollment":80},{"nctId":"NCT01247259","phase":"NA","title":"Efficacy of Sublingual Immunotherapy in Polysensitized Allergic Rhinitis Patients","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2007-11","conditions":"Allergic Rhinitis","enrollment":134},{"nctId":"NCT01224834","phase":"PHASE1","title":"Safety and Tolerability Study of Ragweed SLIT Tablets","status":"COMPLETED","sponsor":"Stallergenes Greer","startDate":"2009-01","conditions":"Rhinitis, Allergic, Seasonal, Ragweed Pollen Allergy","enrollment":60},{"nctId":"NCT00987909","phase":"PHASE2","title":"Exposure Chamber Trial With Cat Immunotherapy","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2009-09","conditions":"Cat Allergy","enrollment":60}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ANAPHYLACTIC REACTION"}],"_approvalHistory":[],"publicationCount":99,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Staloral 300 IR, Stallergenes, France"],"phase":"marketed","status":"active","brandName":"sublingual allergen extract","genericName":"sublingual allergen extract","companyName":"Medical University of Lodz","companyId":"medical-university-of-lodz","modality":"Biologic","firstApprovalDate":"","aiSummary":"Sublingual allergen extract desensitizes the immune system by gradually exposing it to increasing doses of allergen under the tongue, promoting immune tolerance. Used for Allergic rhinitis, Allergic asthma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}